Arcturus Therapeutics Holdings Inc. generated $82.0M in revenue in fiscal year 2025. This represents a decrease of 46.1% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $29.4M in revenue. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Arcturus Therapeutics Holdings Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ARCT Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
ARCT Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Arcturus Therapeutics Holdings Inc. financials
Frequently Asked Questions
What was Arcturus Therapeutics Holdings Inc.'s revenue in fiscal year 2025?
Arcturus Therapeutics Holdings Inc. generated $82.0M in revenue in fiscal year 2025.
How fast is Arcturus Therapeutics Holdings Inc.'s revenue growing?
Arcturus Therapeutics Holdings Inc. (ARCT) revenue fell by 46.1% year over year, from $152.3M to $82.0M in fiscal year 2025.
What is Arcturus Therapeutics Holdings Inc.'s revenue over the last twelve months?
Arcturus Therapeutics Holdings Inc. (ARCT) reported $29.4M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Arcturus Therapeutics Holdings Inc.'s revenue changed over the years?
Across the 8 fiscal years this page covers, Arcturus Therapeutics Holdings Inc. (ARCT) revenue went from $15.8M in fiscal year 2018 to $82.0M in fiscal year 2025.
What was Arcturus Therapeutics Holdings Inc.'s revenue in the most recent quarter?
Arcturus Therapeutics Holdings Inc. (ARCT) reported $3.0M in revenue in Q2 2026. This represents a decrease of 89.5% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Arcturus Therapeutics Holdings Inc. (ARCT) reported on that line in every period on record.